Ellodi Pharmaceuticals competitive analysis

Explore patent oppositions filed by Ellodi Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The EsophagusDR. FALK PHARMA GMBHNov 6, 2019
Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The EsophagusDR. FALK PHARMA GMBHJun 26, 2019

Explore Ellodi Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 25, 2023Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis1
Jul 31, 2019Orally Administered Corticosteroid Compositions1
Aug 1, 2018Orally Administered Corticosteroid Compositions1

Latest PTAB cases involving Ellodi Pharmaceuticals

Discover the latest PTAB cases involving Ellodi Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 16, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Ellodi Pharmaceuticals

PGR2025-00086Sep 19, 2025DR FALK PHARMAELLODI PHARMACEUTICALSTerminated-Adverse Judgment
PGR2025-00086Sep 19, 2025DR. FALK PHARMA GMBHELLODI PHARMACEUTICALSTerminated-Adverse Judgment
IPR2025-00052Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTerminated-Adverse Judgment
IPR2025-00052Oct 24, 2024DR. FALK PHARMA GMBHELLODI PHARMACEUTICALS LPTerminated-Adverse Judgment
IPR2025-00054Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTerminated-Adverse Judgment
IPR2025-00054Oct 24, 2024DR. FALK PHARMA GMBHELLODI PHARMACEUTICALS LPTerminated-Adverse Judgment
IPR2025-00055Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTerminated-Adverse Judgment
IPR2025-00055Oct 24, 2024DR. FALK PHARMA GMBHELLODI PHARMACEUTICALS LPTerminated-Adverse Judgment
IPR2025-00056Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTerminated-Adverse Judgment
IPR2025-00056Oct 24, 2024DR. FALK PHARMA GMBHELLODI PHARMACEUTICALS LPTerminated-Adverse Judgment

Peer Comparison New

IP litigation analysis comparing Ellodi Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ELLODI PHARMACEUTICALS LP - - - 5
DR FALK PHARMA - - 6 -
DR. FALK PHARMA GMBH1046 -